BiotechTube
Home/Oryx Translational Medicine/Dr. Dr. Michael Dahm
DD

Dr. Dr. Michael Dahm

Chief Medical Officer

Oryx Translational Medicine

Therapeutic Areas

Oncology

Oryx Translational Medicine Pipeline

DrugIndicationPhase
ParvOryxRecurrent Glioblastoma / Solid CancersPhase 1/2
VicOryxSolid CancersPhase 1/2
MicOryxSolid CancersPhase 1/2

Leadership Team at Oryx Translational Medicine

DB
Dr. Bernard Huber
Chief Executive Officer
DO
Dr. Ottheinz Krebs
Chief Operating Officer
View full Oryx Translational Medicine profile